Role of Neutrophil Extracellular Traps in AAA Pathogenesis

中性粒细胞胞外陷阱在 AAA 发病机制中的作用

基本信息

批准号：
9321216
负责人：
Gilbert Rivers Upchurch
金额：
$ 12.64万
依托单位：
UNIVERSITY OF VIRGINIA
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-08-01 至 2018-03-01
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9321216
关键词：
Abdomen Abdominal Aortic Aneurysm Acute Adoptive Transfer Adult Aneurysm Angiotensin II Aorta Aortic Rupture ApoE knockout mouse Arts Atherosclerosis Blood Cells Cellular Infiltration Cessation of life Chronic Chronic Disease Coculture Techniques Confocal Microscopy DNA Data Defense Mechanisms Deoxyribonucleases Development Disease Elastases Enzymes Exhibits Experimental Models Extracellular Matrix Degradation Flow Cytometry Foundations Gelatinase A Genetic Gout Growth Hemorrhage High Mobility Group Proteins Histones Human Human Volunteers ITGAM gene Image Immune Immune system Immunofluorescence Immunologic Immunohistochemistry Impairment In Vitro Infiltration Inflammation Inflammatory Inflammatory Response Infusion procedures Injury Interleukin-1 beta Knock-out Knockout Mice Leukocyte Elastase Life Literature Lymphocyte Medial Mediating Medical Methods Modeling Mus Necrosis Neutrophil Activation Operative Surgical Procedures Pathogenesis Pathologic Patients Perfusion Peroxidases Phagocytosis Pharmacological Treatment Pharmacology Plasma Play Postoperative Period Process Proteins Proteomics Publishing Recruitment Activity Research Role Rupture Ruptured Abdominal Aortic Aneurysm Scanning Electron Microscopy Sepsis Shock Signal Transduction Staining method Stains Sterility Testing Thrombosis Tissues Trauma Vasculitis Western Blotting Work abdominal aorta anakinra cell type extracellular immunocytochemistry inflammatory marker inhibitor/antagonist innovation intravital microscopy knock-down microscopic imaging neutrophil novel therapeutics peripheral blood public health relevance recombinant human DNase repaired response response to injury treatment strategy

项目摘要

DESCRIPTION (provided by applicant): Neutrophils are the early responders to acute inflammation during vessel wall injury or insult. Apart from phagocytosis and degranulation, NETosis (formation of Neutrophil Extracellular Trap or NET) is another aspect of neutrophil-mediated defense mechanism. Multiple proteins/enzymes such as histones, neutrophil elastase and myeloperoxidase are released along with NETs. Therefore, induction of NETosis in sterile inflammation is deleterious for many chronic diseases such as atherosclerosis. Abdominal aortic aneurysms (AAAs) remain a life-threatening disease in US adults with no available nonsurgical therapies highlighting a great need to develop a treatment strategy. During AAA formation, aortic wall undergoes major pathological changes with degradation of extracellular matrix and marked infiltration of inflammatory cells, such as neutrophils and lymphocytes. In murine experimental models, neutrophils have been detected in early stages of AAA growth. Recently, we have shown that genetic (IL-1ß and IL-1R1 deficiency in mice) and pharmacological (anakinra treatment) inhibition of IL-1ß signaling protect mice from AAA formation with significant reduction in aortic infiltration of inflammatory cells including neutrophils. Our preliminary result and published literatures suggest that IL-1ß induces NETosis in neutrophils. Therefore, we hypothesize that aortic IL-1ß induces NETosis and exacerbates inflammation in AAA. To test this hypothesis, we are proposing three specific aims. First we will test if genetic and pharmacological inhibition of IL-1ß signaling suppress NETosis and the AAA growth in mice. For these aims, we will use C57BL/6 (wild-type, WT), IL-1ß knockout (KO) and IL-1R1 KO mice, mouse AAA models such as elastase perfusion and angiotensin II infusion, knockdown IL-1ß or IL-1R1 using AMAXA Nucleofector, adoptive transfer of IL-1R1 KO neutrophils to neutrophil depleted WT mice. To examine and quantify NETosis, we will use the state-of-the-arts immunohistochemistry, confocal and intravital microscopy, and imaging flow cytometry. We will show that NET formation promotes inflammation and AAA growths, and, pharmacological inhibition of NETosis by (i) impairing IL-1ß signaling (using anakinra) and (ii) degrading NETs (using DNase), suppresses AAA growth in mice. We will further test the hypothesis that human neutrophils exhibit IL-1ß-dependent NETosis and induce inflammation in human aortic wall ex vivo. We will use proteomics approaches to identify proinflammatory proteins in human NETs, use human aortic explants to examine inflammatory response of IL-1b-induced NETs and parallel flow chambers to examine IL-1ß-induced NET-mediated immune cell recruitment from blood. Altogether, this proposal includes innovative concept that IL-1ß synthesized in aortic wall induces NETosis leading to increased tissue inflammation and AAA growth, and innovative methods to reduce NETosis and suppress AAA growth. These aims when achieved will provide the foundation for developing novel therapies for AAAs in human.

描述（由申请人提供）：中性粒细胞是血管壁损伤或损伤期间急性炎症的早期反应者，除了吞噬作用和脱粒作用外，NETosis（中性粒细胞胞外陷阱或NET的形成）是中性粒细胞介导的多种蛋白质的另一个方面。 /组蛋白、中性粒细胞弹性蛋白酶和髓过氧化物酶等酶与 NET 一起释放，因此，诱导 NETosis。无菌炎症对动脉粥样硬化等许多慢性疾病是有害的。腹主动脉瘤 (AAA) 仍然是美国成年人的一种危及生命的疾病，目前尚无可用的非手术疗法，这凸显了在 AAA 形成过程中非常需要制定治疗策略。病理变化表现为细胞外基质降解和炎症细胞（如中性粒细胞和淋巴细胞）明显浸润。在小鼠实验模型中，已检测到中性粒细胞。最近，我们发现通过遗传（小鼠中 IL-1ß 和 IL-1R1 缺陷）和药物（阿那白滞素治疗）抑制 IL-1ß 信号可保护小鼠免受 AAA 形成，并显着减少主动脉浸润。我们的初步结果和已发表的文献表明，IL-1ß 会诱导中性粒细胞中的 NETosis，因此，我们发现主动脉 IL-1ß 会诱导 NETosis。为了验证这一假设，我们提出了三个具体目标：首先，我们将测试 IL-1ß 信号传导的遗传和药理学抑制是否会抑制小鼠中的 NETosis 和 AAA 生长。 /6（野生型，WT），IL-1ß敲除（KO）和IL-1R1 KO小鼠，小鼠AAA模型，例如弹性蛋白酶灌注和血管紧张素II输注，敲低使用 AMAXA Nucleofector 将 IL-1ß 或 IL-1R1 过继转移至中性粒细胞耗尽的 WT 小鼠中为了检查和量化 NETosis，我们将使用最先进的免疫组织化学、共聚焦和活体显微镜，以及我们将证明 NET 的形成促进炎症和 AAA 的生长，以及对 NETosis 的药理学抑制。通过 (i) 损害 IL-1ß 信号传导（使用阿那白滞素）和 (ii) 降解 NETs（使用 DNase），抑制小鼠体内的 AAA 生长。我们将进一步检验人类中性粒细胞表现出 IL-1ß 依赖性 NETosis 并诱导炎症的假设。我们将使用蛋白质组学方法来鉴定人类 NET 中的促炎蛋白，并使用人类主动脉外植体来检查 NET 的炎症反应。 IL-1b 诱导的 NET 和平行流室检查 IL-1ß 诱导的 NET 介导的血液中免疫细胞募集总而言之，该提案包括主动脉壁中合成的 IL-1ß 诱导 NETosis 导致组织炎症和 AAA 增加的创新概念。生长，以及减少 NETosis 和抑制 AAA 生长的创新方法，这些目标一旦实现，将为开发人类 AAA 的新疗法奠定基础。